Variant report

Variant	esv32996
Chromosome Location	chr9:95834483-95837796
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:43)
CpG islands
(count:61)
Chromatin interactive
region (count:15)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:43 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BHLHE40	chr9:95834531-95835139	K562	blood:	n/a	n/a
2	EP300	chr9:95834589-95835079	SK-N-SH_RA	brain:	n/a	n/a
3	ESR1	chr9:95834465-95834808	T-47D	breast:	n/a	chr9:95834666-95834683 chr9:95834665-95834682 chr9:95834666-95834681 chr9:95834497-95834514
4	ESR1	chr9:95834563-95834784	T-47D	breast:	n/a	chr9:95834666-95834683 chr9:95834665-95834682 chr9:95834666-95834681
5	ESR1	chr9:95834479-95834847	T-47D	breast:	n/a	chr9:95834666-95834683 chr9:95834665-95834682 chr9:95834666-95834681 chr9:95834497-95834514
6	GATA2	chr9:95834557-95835078	SH-SY5Y	brain:	n/a	n/a
7	GATA3	chr9:95834326-95835222	MCF-7	breast:	n/a	n/a
8	GATA3	chr9:95834169-95835116	MCF-7	breast:	n/a	n/a
9	GATA3	chr9:95834364-95835294	MCF-7	breast:	n/a	n/a
10	HCFC1	chr9:95834845-95834895	K562	blood:	n/a	n/a
11	HMGN3	chr9:95834594-95834773	K562	blood:	n/a	n/a
12	MAX	chr9:95834602-95835164	MCF-7	breast:	n/a	chr9:95834964-95834973 chr9:95834963-95834974
13	MAZ	chr9:95833866-95834604	K562	blood:	n/a	chr9:95834448-95834458
14	MYC	chr9:95834908-95835016	MCF10A-Er-Src	breast:	n/a	chr9:95834964-95834973 chr9:95834963-95834974
15	NFIC	chr9:95834419-95835237	SK-N-SH	brain:	n/a	n/a
16	NR2F2	chr9:95834304-95835224	MCF-7	breast:	n/a	n/a
17	PBX3	chr9:95834440-95835029	SK-N-SH	brain:	n/a	n/a
18	PBX3	chr9:95834451-95834977	SK-N-SH	brain:	n/a	n/a
19	POLR2A	chr9:95834411-95834620	GM12878	blood:	n/a	n/a
20	POLR2A	chr9:95835334-95835406	K562	blood:	n/a	n/a
21	POLR2A	chr9:95835433-95835503	K562	blood:	n/a	n/a
22	POLR2A	chr9:95835224-95835240	K562	blood:	n/a	n/a
23	POLR2A	chr9:95835313-95835319	K562	blood:	n/a	n/a
24	POLR2A	chr9:95834846-95834987	K562	blood:	n/a	n/a
25	POLR2A	chr9:95833845-95834572	K562	blood:	n/a	n/a
26	RCOR1	chr9:95834868-95835100	K562	blood:	n/a	n/a
27	USF1	chr9:95834755-95835180	ECC-1	luminal epithelium:	n/a	chr9:95834963-95834974
28	USF1	chr9:95834783-95835071	A549	lung:	n/a	chr9:95834963-95834974
29	USF1	chr9:95834712-95835129	SK-N-SH_RA	brain:	n/a	chr9:95834963-95834974
30	USF1	chr9:95834743-95835102	K562	blood:	n/a	chr9:95834963-95834974
31	USF1	chr9:95834797-95835104	SK-N-SH_RA	brain:	n/a	chr9:95834963-95834974
32	USF1	chr9:95834821-95835049	HepG2	liver:	n/a	chr9:95834963-95834974
33	USF1	chr9:95834801-95835175	A549	lung:	n/a	chr9:95834963-95834974
34	USF1	chr9:95834744-95835121	K562	blood:	n/a	chr9:95834963-95834974
35	USF1	chr9:95834757-95835185	A549	lung:	n/a	chr9:95834963-95834974
36	USF1	chr9:95834751-95835197	ECC-1	luminal epithelium:	n/a	chr9:95834963-95834974
37	USF1	chr9:95834790-95835080	A549	lung:	n/a	chr9:95834963-95834974
38	USF1	chr9:95834885-95835048	HepG2	liver:	n/a	chr9:95834963-95834974
39	USF1	chr9:95834808-95835035	A549	lung:	n/a	chr9:95834963-95834974
40	USF1	chr9:95834641-95835225	SK-N-SH	brain:	n/a	chr9:95834963-95834974
41	USF2	chr9:95834870-95835115	Hela-S3	cervix:	n/a	chr9:95834963-95834974
42	USF2	chr9:95834970-95835000	HepG2	liver:	n/a	n/a
43	ZNF217	chr9:95834512-95835129	MCF-7	breast:	n/a	n/a

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr9:95834820-95834870	NHDF-neo	bronchial:	n/a
2	chr9:95834820-95834870	NT2-D1	testis:	n/a
3	chr9:95834820-95834870	GM06990	blood:	n/a
4	chr9:95834820-95834870	HUVEC	blood vessel:	n/a
5	chr9:95834820-95834870	SK-N-MC	brain:	n/a
6	chr9:95834820-95834870	LNCaP	prostate:	n/a
7	chr9:95834820-95834870	HepG2	liver:	n/a
8	chr9:95834820-95834870	AG10803	skin:	n/a
9	chr9:95834820-95834870	Hela-S3	cervix:	n/a
10	chr9:95834820-95834870	HMEC	breast:	n/a
11	chr9:95834820-95834870	BJ	skin:	n/a
12	chr9:95834820-95834870	GM12891	blood:	n/a
13	chr9:95834820-95834870	HRPEpiC	eye:	n/a
14	chr9:95834820-95834870	NB4	blood:	n/a
15	chr9:95834820-95834870	SK-N-SH	brain:	n/a
16	chr9:95834820-95834870	U87	brain:	n/a
17	chr9:95834820-95834870	AG09309	skin:	n/a
18	chr9:95834820-95834870	Hepatocyte	liver:	n/a
19	chr9:95834820-95834870	Caco-2	colon:	n/a
20	chr9:95834820-95834870	HCT-116	colon:	n/a
21	chr9:95834820-95834870	HIPEpiC	eye:	n/a
22	chr9:95834820-95834870	SK-N-SH_RA	brain:	n/a
23	chr9:95834820-95834870	HCM	heart:	n/a
24	chr9:95834820-95834870	RPTEC	kidney:	n/a
25	chr9:95834820-95834870	PrEC	prostate:	n/a
26	chr9:95834820-95834870	K562	blood:	n/a
27	chr9:95834820-95834870	HRCEpiC	kidney:	n/a
28	chr9:95834820-95834870	ovcar-3	ovarian:	n/a
29	chr9:95834820-95834870	ECC-1	luminal epithelium:	n/a
30	chr9:95834820-95834870	HL-60	blood:	n/a
31	chr9:95834820-95834870	PFSK-1	brain:	n/a
32	chr9:95834820-95834870	BE2_C	brain:	n/a
33	chr9:95834820-95834870	IMR90	lung:	fetal
34	chr9:95834820-95834870	PANC-1	pancreas:	n/a
35	chr9:95834820-95834870	NHBE	bronchial:	n/a
36	chr9:95834820-95834870	Jurkat	blood:	n/a
37	chr9:95834820-95834870	HCF	heart:	n/a
38	chr9:95834820-95834870	MCF-7	breast:	n/a
39	chr9:95834820-95834870	AoSMC	blood vessel:	n/a
40	chr9:95834820-95834870	T-47D	breast:	n/a
41	chr9:95834820-95834870	SAEC	small airway:	n/a
42	chr9:95834820-95834870	A549	lung:	n/a
43	chr9:95834820-95834870	CMK	blood:	n/a
44	chr9:95834820-95834870	HPAEpiC	pulmonary alveolar:	n/a
45	chr9:95834820-95834870	ProgFib	skin:	n/a
46	chr9:95834820-95834870	GM19239	blood:	n/a
47	chr9:95834820-95834870	MCF10A-Er-Src	breast:	n/a
48	chr9:95834820-95834870	AG04449	skin:	fetal
49	chr9:95834820-95834870	HAEpiC	amniotic membrane:	n/a
50	chr9:95834820-95834870	AG09319	gingival:	n/a

(count:15 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr9:95832871..95835719-chr9:95837234..95839354,3	K562	blood:
2	chr9:95833654..95836498-chr9:95895310..95897645,2	MCF-7	breast:
3	chr9:95750405..95751264-chr9:95834116..95834978,4	MCF-7	breast:
4	chr9:95825270..95827646-chr9:95832621..95835628,3	K562	blood:
5	chr9:95817800..95819873-chr9:95833973..95836077,2	MCF-7	breast:
6	chr9:95822333..95825278-chr9:95837106..95839130,2	K562	blood:
7	chr9:95832871..95836106-chr9:95837234..95840291,5	K562	blood:
8	chr9:95818455..95825266-chr9:95831322..95836031,9	K562	blood:
9	chr9:95821374..95823833-chr9:95837106..95839340,2	K562	blood:
10	chr9:95832455..95836206-chr9:95854622..95857563,3	K562	blood:
11	chr9:95836433..95839716-chr9:95857112..95859534,3	K562	blood:
12	chr9:95818565..95822101-chr9:95835996..95838138,3	MCF-7	breast:
13	chr9:95833185..95836026-chr9:95840723..95843661,2	MCF-7	breast:
14	chr9:95827710..95829227-chr9:95833647..95835917,2	K562	blood:
15	chr9:95832871..95835719-chr9:95837234..95839354,3	K562	blood:

No data

Variant related genes	Relation type
SUSD3	TF binding region
SUSD3	CpG island
ENSG00000165233	chromatin interactions
ENSG00000131669	chromatin interactions
ENSG00000223446	chromatin interactions
ENSG00000157303	chromatin interactions

Extended variants
information (count: 147 )
Associated
traits (count: 73 )

Variant overlapped rSNPs/rCNVs (count:147 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs374609648	chr9:95834496-95834497	Enhancers Weak transcription Genic enhancers Strong transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs530930611	chr9:95834521-95834522	Enhancers Weak transcription Genic enhancers Strong transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs147530906	chr9:95834524-95834525	Enhancers Weak transcription Genic enhancers Strong transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs532007572	chr9:95834549-95834550	Enhancers Weak transcription Genic enhancers Strong transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs550239106	chr9:95834578-95834579	Enhancers Weak transcription Genic enhancers Strong transcription Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs564223858	chr9:95834624-95834625	Enhancers Weak transcription Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs528530221	chr9:95834671-95834672	Enhancers Weak transcription Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs184645757	chr9:95834688-95834689	Enhancers Weak transcription Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs555344127	chr9:95834713-95834714	Enhancers Weak transcription Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs139895240	chr9:95834749-95834750	Enhancers Weak transcription Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs529856230	chr9:95834757-95834758	Enhancers Weak transcription Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs368633804	chr9:95834774-95834775	Enhancers Weak transcription Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs76789653	chr9:95834775-95834776	Enhancers Weak transcription Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs78357512	chr9:95834776-95834777	Enhancers Weak transcription Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs368713629	chr9:95834795-95834796	Enhancers Weak transcription Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs558556090	chr9:95834807-95834808	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs570485581	chr9:95834844-95834845	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs534661359	chr9:95834845-95834846	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs150644253	chr9:95834879-95834880	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs553164612	chr9:95834968-95834969	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs7018579	chr9:95834985-95834986	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
22	rs139730859	chr9:95835017-95835018	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs112585240	chr9:95835023-95835024	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs571771890	chr9:95835075-95835076	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs368327859	chr9:95835101-95835102	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs557613169	chr9:95835163-95835164	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
27	rs557630454	chr9:95835196-95835197	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
28	rs181332211	chr9:95835198-95835199	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
29	rs183979464	chr9:95835199-95835200	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
30	rs576007796	chr9:95835219-95835220	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
31	rs542981783	chr9:95835223-95835224	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
32	rs564110631	chr9:95835264-95835265	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
33	rs77231843	chr9:95835280-95835281	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
34	rs540288094	chr9:95835366-95835367	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
35	rs189827536	chr9:95835419-95835420	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs114810646	chr9:95835428-95835429	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs548110492	chr9:95835445-95835446	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
38	rs145030773	chr9:95835448-95835449	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
39	rs139909674	chr9:95835450-95835451	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
40	rs552504487	chr9:95835456-95835457	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
41	rs570424685	chr9:95835470-95835471	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
42	rs146746604	chr9:95835474-95835475	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
43	rs546671967	chr9:95835478-95835479	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
44	rs568091352	chr9:95835484-95835485	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
45	rs536033604	chr9:95835493-95835494	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
46	rs557239466	chr9:95835508-95835509	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs573555207	chr9:95835527-95835528	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs77544256	chr9:95835544-95835545	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs559141646	chr9:95835553-95835554	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs575453465	chr9:95835559-95835560	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:73)

Disease	PMID	Source
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Medulloblastoma	21979893	CNVD
microdeletion syndrome	16199537	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Cancer	20164919	CNVD
Urothelial carcinoma	21177765	CNVD
Renal cell carcinoma	21668985	CNVD
Autism	22495311	CNVD
Melanoma	18172304	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	16751803	CNVD
Myelofibrosis	22110671	CNVD
lymphocytic leukemia	21291569	CNVD
Leukemia	17361228	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Glioblastoma	16823260	CNVD
Leukemia	18688285	CNVD
Non-small cell lung cancer	21044232	CNVD
Brain cancer	20823417	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Astrocytoma	17387387	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Renal cell carcinoma	19461508	CNVD
Neuroblastoma	18923191	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Heart disease	21282601	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Lung cancer	18438408	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Acute myeloid leukemia	21251322	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Breast cancer	17603634	CNVD
Acute myeloid leukemia	20729466	CNVD
Oral cancer	21386901	CNVD
Bipolar disorder	18458673	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Wilms tumour	21544195	CNVD
Prostate cancer	18632612	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Gastric cancer	17908304	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Gastrointestinal stromal cancer	20877625	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Biliary cancer	19435499	CNVD
small cell lung cancer	20016488	CNVD
Intracranial aneurysm	16715129	CNVD
Cardiac fibroma	18329553	CNVD
Mental retardation	21693067	CNVD
Breast cancer	17133270	CNVD
Basal cell nevus syndrome	21572526	CNVD
Mental retardation	19951919	CNVD
Retinoblastoma	22278416	CNVD
9q22.3 microdeletion syndrome	22283845	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Microcephaly	18830227	CNVD
overgrowth syndrome	16570072	CNVD
Cancer	17440070	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:162 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:95824600-95854000	Weak transcription	Gastric	stomach
2	chr9:95827600-95839800	Genic enhancers	Primary T helper cells fromperipheralblood	blood
3	chr9:95828200-95841600	Weak transcription	Duodenum Mucosa	Duodenum
4	chr9:95828400-95834600	Weak transcription	Adipose Nuclei	Adipose
5	chr9:95828400-95834600	Weak transcription	Brain Cingulate Gyrus	brain
6	chr9:95828400-95834600	Weak transcription	Fetal Intestine Small	intestine
7	chr9:95828400-95834600	Weak transcription	Lung	lung
8	chr9:95828400-95840000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
9	chr9:95828600-95840000	Weak transcription	Monocytes-CD14+_RO01746	blood
10	chr9:95828600-95845000	Weak transcription	Primary monocytes fromperipheralblood	blood
11	chr9:95830600-95840200	Weak transcription	Primary hematopoietic stem cells	blood
12	chr9:95830800-95836200	Genic enhancers	Primary T helper naive cells fromperipheralblood	blood
13	chr9:95831400-95836400	Genic enhancers	Primary T cells fromperipheralblood	blood
14	chr9:95831800-95834800	Weak transcription	Primary hematopoietic stem cells short term culture	blood
15	chr9:95831800-95837400	Strong transcription	Primary T cells from cord blood	blood
16	chr9:95832800-95838600	Enhancers	Primary T killer naive cells fromperipheralblood	blood
17	chr9:95833000-95835400	Enhancers	Primary T killer memory cells from peripheral blood	blood
18	chr9:95833000-95842800	Weak transcription	GM12878-XiMat	blood
19	chr9:95833200-95837600	Enhancers	Colon Smooth Muscle	Colon
20	chr9:95833400-95834600	Weak transcription	Psoas Muscle	Psoas
21	chr9:95833400-95834800	Strong transcription	Primary B cells from cord blood	blood
22	chr9:95833400-95835000	Enhancers	K562	blood
23	chr9:95833400-95835400	Enhancers	Skeletal Muscle Female	skeletal muscle
24	chr9:95833600-95835600	Enhancers	Fetal Muscle Leg	muscle
25	chr9:95833600-95837400	Enhancers	Primary T helper cells PMA-I stimulated	--
26	chr9:95833800-95834600	Enhancers	Stomach Smooth Muscle	stomach
27	chr9:95833800-95836800	Enhancers	Ovary	ovary
28	chr9:95834000-95834600	Genic enhancers	Primary neutrophils fromperipheralblood	blood
29	chr9:95834000-95834600	Enhancers	Rectal Smooth Muscle	rectum
30	chr9:95834000-95835000	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
31	chr9:95834000-95835200	Genic enhancers	Primary T regulatory cells fromperipheralblood	blood
32	chr9:95834000-95835200	Enhancers	Dnd41	blood
33	chr9:95834000-95835400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
34	chr9:95834000-95835400	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
35	chr9:95834000-95835400	Enhancers	Liver	Liver
36	chr9:95834000-95835400	Enhancers	Placenta	Placenta
37	chr9:95834000-95835600	Enhancers	Breast Myoepithelial Primary Cells	Breast
38	chr9:95834200-95834800	Genic enhancers	Primary mononuclear cells fromperipheralblood	Blood
39	chr9:95834200-95835000	Genic enhancers	Primary B cells from peripheral blood	blood
40	chr9:95834200-95835000	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
41	chr9:95834200-95835000	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
42	chr9:95834200-95835000	Enhancers	Right Atrium	heart
43	chr9:95834200-95835200	Enhancers	Right Ventricle	heart
44	chr9:95834200-95835400	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
45	chr9:95834200-95835400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
46	chr9:95834200-95835400	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
47	chr9:95834200-95835400	Enhancers	Esophagus	oesophagus
48	chr9:95834200-95835400	Enhancers	Sigmoid Colon	Sigmoid Colon
49	chr9:95834200-95835400	Genic enhancers	Spleen	Spleen
50	chr9:95834200-95835600	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links